Early hyperglycemia may influence cancer risk after type 2 diabetes diagnosis. See what a large cohort study found about early glycemic exposure.
Read More »Numbness Isn’t Always Diabetic Neuropathy: The Metformin-B12 Connection That’s Easy to Miss
Metformin B12 deficiency can cause numbness that resembles diabetic neuropathy. Learn who is at risk, when to test B12, and why early detection matters.
Read More »Fiber’s Unexpected Bonus: Diabetes Data Show BP Benefit
New trial data suggest dietary fiber supplementation may lower systolic blood pressure in adults with type 2 diabetes and hypertension.
Read More »Type 2 Diabetes Damages the Pancreas, Or Does It?
New research challenges assumptions about the exocrine pancreas in type 2 diabetes and what pancreatic findings may mean for clinical care.
Read More »Can Psychotherapy Lower Blood Sugar? New Evidence Finds a Link Between Mind and Metabolism
Discover how psychotherapy for type 2 diabetes may improve A1C, support self-management, and influence weight and metabolic health.
Read More »Frozen Shoulder and Diabetes: The Overlooked Complication That Can Steal Mobility
Diabetes complications are often discussed in terms of the heart, kidneys, eyes, and nerves. However, diabetes can also affect joints and connective tissue. Adhesive capsulitis, or frozen shoulder, is one diabetes-related complication that deserves more attention. It can begin with ordinary shoulder pain and gradually make simple movements surprisingly difficult. …
Read More »Low Potassium, Higher Diabetes Risk? A Surprising Clue From Heart Failure Research
Low potassium is usually viewed through a cardiovascular lens, especially in patients with heart failure. However, emerging evidence suggests clinicians may have another reason to pay attention. New research examining the relationship between hypokalemia and diabetes risk found that lower serum potassium levels were associated with a greater risk of …
Read More »SGLT Inhibitors Protect the Heart and Kidneys: Why Is Type 1 Diabetes Still the Exception?
SGLT inhibitors have changed the treatment landscape for cardiovascular and kidney disease, particularly in people with type 2 diabetes, heart failure, and chronic kidney disease. That success raises an obvious question: why are SGLT inhibitors in type 1 diabetes still largely outside routine clinical practice? The answer is not a …
Read More »Beyond Pain Relief: Can Spinal Cord Stimulation Restore Sensation in Diabetic Neuropathy?
For people with painful diabetic neuropathy (PDN), treatment has traditionally focused on controlling burning, stabbing, and shooting pain. However, emerging research on spinal cord stimulation for diabetic neuropathy raises a more intriguing question: Could neuromodulation also improve sensation? Results from the SENZA-PDN clinical trial suggest that some patients receiving high-frequency …
Read More »Could a Simple Blood Test Predict a Heart Event in Type 2 Diabetes?
Could a routine blood sample someday reveal cardiovascular danger that cholesterol, blood pressure, and HbA1c do not fully capture? New research suggests that epigenetic cardiovascular risk prediction could offer a new way to identify people with type 2 diabetes who face a higher short-term risk of major cardiovascular events. Instead …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.